ArticleScientific reports2026
Monitoring and health risk assessment of disinfection byproducts in drinking water in Chengdu, China, 2023-2025.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To characterize the occurrence levels and distribution of disinfection byproducts in drinking water of Chengdu in China, evaluate health risks to the adult population via oral, dermal, and inhalation exposure routes, and identify key health risk drivers. From 2023 to 2025, water samples were collected from 118 centralized water supply units across 23 districts to detect trihalomethanes and haloacetic acid disinfection byproducts, analyze differences in detection and concentration levels across water periods, regions, and water supply scales, and applied the US EPA health risk assessment model to assess exposure risks of trichloromethane, bromodichloromethane, dibromochloromethane, tribromomethane, dichloroacetic acid, and trichloroacetic acid through oral and dermal routes. All 4464 samples had disinfection byproduct concentrations met national standards, with 100.0% pass rate. Trichloromethane had the highest detection rate (86.0%) and median concentration (9.00 µ g/L). Concentrations of trichloromethane, bromodichloromethane, dichloroacetic acid, and trichloroacetic acid were higher in the wet season than in the dry season. Trichloromethane and bromodichloromethane concentrations were higher in urban versus rural samples, whereas dibromochloromethane and dichloroacetic acid were higher in rural areas. Detection rates and concentrations in large centralized water supply units exceeded those in small units (P < 0.05). The health risk assessment showed that the cumulative non-carcinogenic risk (HI < 1) was within acceptable limits, and the cumulative carcinogenic risk (TCR = 4.15 × 10⁻⁵) fell within the commonly used regulatory benchmark range but warrants continued attention. Trichloromethane contributed the largest share (26.5%). Disinfection byproduct concentrations in Chengdu's drinking water comply with national standards, and the associated non‑carcinogenic health risks are low. The cumulative carcinogenic risk is within the commonly accepted benchmark range but is sufficiently elevated to justify continued surveillance and source‑control measures, with trichloromethane and trichloroacetic acid as priority compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.